Avanos Medical AVNS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | $7.2M-21.7% | $9.2M+16.5% | $7.9M+17.9% | $6.7M+34.0% | $5M+85.2% | |
| Total Specialty Nutrition Systems | $84.6M+2.4% | $82.6M-5.2% | $87.1M+5.3% | $82.7M-4.4% | $86.5M+7.1% | |
| Other segment items by Business | ||||||
| PM&R | -$100K0.0% | -$100K— | —— | —— | —— | |
| General expenses by Business | ||||||
| PM&R | -$48.1M+0.8% | -$48.5M-5.4% | -$46M-4.8% | -$43.9M-9.5% | -$40.1M-5.5% | |
| Total Specialty Nutrition Systems | -$72.8M-4.7% | -$69.5M-6.3% | -$65.4M-6.3% | -$61.5M-8.3% | -$56.8M-4.0% | |
| Currency translation adjustment by Business | ||||||
| PM&R | $2M-23.1% | $2.6M— | —— | —— | —— | |
| Total Specialty Nutrition Systems | $0— | $0— | —— | —— | —— | |
| Advertising, promotion and selling expenses by Business | ||||||
| PM&R | -$63.3M-1.6% | -$62.3M+5.7% | -$66.1M+3.6% | -$68.6M+6.3% | -$73.2M+6.2% | |
| Total Specialty Nutrition Systems | -$56.9M-6.2% | -$53.6M+4.3% | -$56M+4.1% | -$58.4M+5.5% | -$61.8M+7.8% | |
| Cost of goods sold by Business | ||||||
| PM&R | -$86.7M-1.2% | -$85.7M+0.3% | -$86M-0.1% | -$85.9M-1.4% | -$84.7M-0.5% | |
| Total Specialty Nutrition Systems | -$177.9M-7.8% | -$165.1M-6.9% | -$154.5M-5.6% | -$146.3M-4.8% | -$139.6M-2.9% | |
| Depreciation and amortization expense by Business | ||||||
| PM&R | -$14.5M+1.4% | -$14.7M-2.1% | -$14.4M-1.4% | -$14.2M-2.2% | -$13.9M-3.7% | |
| Total Specialty Nutrition Systems | -$21.5M-5.4% | -$20.4M-11.5% | -$18.3M-4.0% | -$17.6M-2.3% | -$17.2M-4.9% | |
| Distribution by Business | ||||||
| PM&R | -$13.1M-4.0% | -$12.6M-5.9% | -$11.9M-7.2% | -$11.1M-2.8% | -$10.8M-2.9% | |
| Total Specialty Nutrition Systems | -$25.7M-3.2% | -$24.9M0.0% | -$24.9M-3.8% | -$24M-1.3% | -$23.7M+4.0% | |
| Research and development expenses by Business | ||||||
| PM&R | -$5M-4.2% | -$4.8M-2.1% | -$4.7M+13.0% | -$5.4M+15.6% | -$6.4M+12.3% | |
| Total Specialty Nutrition Systems | -$16.3M+2.4% | -$16.7M+2.9% | -$17.2M+1.7% | -$17.5M-1.7% | -$17.2M+0.6% | |
| Goodwill by Business | ||||||
| PM&R | $212.7M-26.2% | $288.3M-20.5% | $362.7M— | —— | —— | |
| Total Specialty Nutrition Systems | $1.35B+1.0% | $1.34B+1.0% | $1.32B— | —— | —— | |
| Net Sales by Product | ||||||
| Enteral feeding | $324.8M+3.2% | $314.7M+2.6% | $306.7M+3.6% | $296M+0.6% | $294.2M+1.6% | |
| Neonate solutions | $131M+10.8% | $118.2M+1.0% | $117M+4.6% | $111.9M+2.9% | $108.7M+1.9% | |
| Radiofrequency ablation | $141.8M+2.0% | $139M+2.1% | $136.2M+2.5% | $132.9M+3.3% | $128.6M+1.9% | |
| Surgical pain and recovery | $96.1M-2.7% | $98.8M-2.0% | $100.8M-2.0% | $102.9M-2.5% | $105.5M-2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
